Core Viewpoint - The individual investor adopts a contrarian investment style, focusing on stocks that have recently experienced sell-offs due to non-recurrent events, particularly when insiders are buying shares at lower prices [1] Investment Strategy - The investment portfolio is split approximately 50%-50% between shares and call options, indicating a balanced approach to risk and potential returns [1] - The investor's timeframe for holding positions typically ranges from 3 to 24 months, suggesting a medium-term investment horizon [1] - Fundamental analysis is employed to assess the health of companies, including their leverage and financial ratios compared to sector and industry averages [1] - Technical analysis is utilized to optimize entry and exit points, with a focus on support and resistance levels on weekly charts [1] Stock Selection Criteria - The investor screens for stocks that have undergone recent sell-offs, particularly those influenced by non-recurrent events, to identify potential buying opportunities [1] - Insider buying at lower prices serves as a key indicator for selecting stocks, reflecting confidence from company executives [1] - Professional background checks are conducted on insiders who purchase shares post-sell-off to ensure credibility and assess motivations [1]

Core Insights - Several U.S. politicians sold UnitedHealth stock shortly before a significant market crash on January 27, 2026, raising concerns about the timing of these transactions [1][6][10] Group 1: Stock Performance and Market Impact - UnitedHealth experienced a dramatic loss of approximately 19% in a single trading session, closing at $282.70, which contributed to a nearly 50% decline in its stock value over the past year [2][9] - The company's market capitalization was significantly affected, erasing tens of billions of dollars and dragging down the Dow Jones Industrial Average [1] Group 2: Revenue Guidance and Financial Concerns - UnitedHealth's revenue guidance for 2026 was projected at about $439 billion, falling short of Wall Street estimates of $454 to $456 billion, which contributed to the stock's decline [9] - Rising medical costs and weaker earnings, along with proposed Medicare Advantage payment increases of only 0.09% for 2027, further exacerbated the situation [9] Group 3: Congressional Stock Transactions - Notable transactions included Rep. Kevin Hern selling UnitedHealth shares valued between $250,001 and $500,000 on December 23, 2025, just weeks before the stock's plunge [3][6] - Rep. Julie Johnson sold shares twice in November and December 2025, with each sale ranging from $1,001 to $15,000, occurring while the stock was still perceived as a defensive play [7] - Rep. Gilbert Cisneros sold shares on November 12, 2025, and later purchased shares on December 19, 2025, shortly before the company's outlook worsened [8]

Core Viewpoint - Tesla, Inc. (NASDAQ:TSLA) shares are experiencing a rise, attributed to market dynamics despite recent concerns over weak electric vehicle (EV) demand and lowered estimates from some analysts [1]. Group 1: Stock Performance - TSLA stock is gaining positive traction, becoming today's Stock of the Day after breaking an important support level [2]. - The stock faced increased selling pressure after breaking the $412 support level, indicating a bearish dynamic as buyers who created the support have exited the market [3][4]. - If the stock continues to decline, it is anticipated that the sell-off may stabilize around the $365 level, which previously acted as resistance and could turn into support [4]. Group 2: Market Dynamics - The breakdown of the support level suggests that sellers are forced to sell at discounts, leading to a downtrend in the stock price [3]. - Traders who sold shares around the $365 mark may regret their decision if the stock price rebounds, leading them to place buy orders at that level, potentially forming new support [5].